3-amino-1-phenylbutane has been researched along with Hypertension in 1 studies
*Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gal, J; Lichtenstein, PS; Zirrolli, JA | 1 |
1 other study(ies) available for 3-amino-1-phenylbutane and Hypertension
| Article | Year |
|---|---|
Labetalol is metabolized oxidatively in humans.
Topics: Adult; Biotransformation; Butylamines; Chromatography, Thin Layer; Female; Humans; Hypertension; Labetalol; Male; Middle Aged; Oxidation-Reduction | 1988 |